First, compared with the healthy control group, the mean RAP1/POT1/TPP1 mRNA expression levels of the patients with MDS were significantly decreased, but the mean TRF1/TRF2/TIN2 mRNA expression levels were increased. The gene discussed is TERF1; the disease is myelodysplastic syndrome.